3.17
-0.94%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Guizhou Yibai Pharmaceutical Co
Its shares trade on Shanghai under the ticker 600594.SS. It has been listed since 23 March 2004. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.86bn and a net loss of CN¥329.6m. At that date it held total assets of CN¥3.44bn and shareholders' equity of CN¥2.19bn.
Guizhou Yibai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Guiyang, Guizhou. The company went IPO on 2004-03-23. The firm provides prescription drugs and over the counter (OTC) products, including injections, capsules, oral liquid, granules and tablets, among others. The firm's products are applied in the treatment of cancer, cardiovascular and cerebrovascular, orthopedics, digestion, gynecology, children and breathing, among others. The firm mainly conducts its businesses within domestic markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 23 Mar 2004
- Employees
- 5,555
- Website
- gzcci.com ↗
Leadership
Pay as last reported
- Qi DouChairman of the Board, since 1995CN¥240,000
- Mr. Yaqi DouVice Chairman of the Board, General Manager, since 2019
- Mr. Xianti ZengFinance Director
- Mr. Xianhong JiangDeputy General Manager, Secretary of the Board
- Ya DouDeputy General Manager, DirectorCN¥154,800
- Mr. Zhiwei WangDeputy General Manager, DirectorCN¥180,000
- Zhigang FengDeputy General ManagerCN¥144,000
- Mr. Jian PuDeputy General Manager
- Shenggui ZhangDirector of Marketing, Deputy General ManagerCN¥206,400
- Xiaohui XiaChief Engineer, since 2013ROL 144,000
- Ning GanDirectorCN¥216,000
- Yuexing ZhuDirectorCN¥216,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Guizhou Yibai Pharmaceutical employs 5,555 full-time employees in Guiyang, China.
- The company manufactures prescription drugs and OTC products like injections and tablets.
- Guizhou Yibai Pharmaceutical focuses on domestic markets within China.
Weaknesses
- Guizhou Yibai Pharmaceutical has no international presence beyond China's domestic market.
- The company's product range is limited to specific medical segments like cancer and cardiovascular treatments.
- Guizhou Yibai Pharmaceutical's business is entirely dependent on the Chinese domestic market.
Opportunities
- Guizhou Yibai Pharmaceutical could expand into international markets for pharmaceutical products.
- The company may develop new products for the growing Chinese healthcare sector.
- Guizhou Yibai Pharmaceutical can leverage its domestic market position to enter new medical segments.
Threats
- Guizhou Yibai Pharmaceutical faces competition from other Chinese pharmaceutical companies.
- The company's reliance on the domestic market exposes it to regulatory changes in China.
- Guizhou Yibai Pharmaceutical's business is vulnerable to economic downturns in China.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.